Literature DB >> 36106307

Predictors of Acute Myocardial Infraction in Patients With Vasculitis: A Nationwide Inpatient Cross-Sectional Study.

Gagan Kaur1, Avreet S Bajwa2, Chia Chi Loh3, Sravani Kommuru4, Hadia Younis5, Yakub Ibrahim6, Syed Nurul Aziz7, Viralkumar Patel8.   

Abstract

Objectives The primary goal of this study is to explore demographic and comorbid factors that increase the hospitalization risk of acute myocardial infarction (AMI) in patients with vasculitis along with the utilization rate of percutaneous coronary intervention (PCI)/angioplasty. Additionally, we aim to study the prevalence of AMI in vasculitis inpatients based on geographical distribution. Methods We conducted a retrospective cohort study using the Nationwide Inpatient Sample (NIS) in 2019 involving 33,210 inpatients hospitalized on emergency-based admissions with a co-diagnosis of vasculitis, subdivided into cohorts without AMI (N = 31,790) and with AMI (N = 1,420) as the primary diagnosis. A binomial logistic regression model was used to evaluate the odds ratio (OR) of predictors associated with AMI in patients with vasculitis compared to the non-AMI cohort. Results The prevalence of AMI in the total inpatient population with vasculitis was 4.28%, with a majority of patients being in the older age group of 51-65 years (63%), males (59.2%), and white (59%). Inpatients with vasculitis having pre-existing co-morbid conditions were at greater risk for AMI, such as obesity (OR 2.84, 95%CI 2.78-2.89), metastatic cancer (OR 1.73, 95%CI 1.26-2.37), complicated hypertension (OR 1.64, 95%CI 1.46-1.85), and arthropathies (OR 1.48, 95%CI 1.30-1.68). The in-hospital mortality rate was significantly higher in the AMI cohort compared to the non-AMI cohort (13% vs 2.9%). The utilization rate of PCI/endovascular angioplasty was 13.02% (185 out of 1,420) and had a lower in-hospital mortality rate compared to those managed by medical treatment (8.1% vs 13.8%). Conclusion AMI is an important differential diagnosis to consider in vasculitis patients admitted into the hospital with chest pain. Due to the low prevalence of vasculitis and diagnostic challenges, these primary conditions can be often missed. There is a greater risk of inpatient mortality among vasculitis patients with AMI. Therefore, a higher index of suspicion should be exercised, especially in elderly males with risk factors. Vasculitis patients with chronic comorbidities such as arthropathies, obesity and hypertension are at a greater risk for suffering from AMI. Careful screening and management of cardiovascular risk factors is mandatory in vasculitis patients.
Copyright © 2022, Kaur et al.

Entities:  

Keywords:  acute myocardial infarcation; arthopathies; coronary vasculitis; diabetes and hypertension; primary percutaneous coronary intervention (pci); risk-factors

Year:  2022        PMID: 36106307      PMCID: PMC9445402          DOI: 10.7759/cureus.27751

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  16 in total

Review 1.  Fourth Universal Definition of Myocardial Infarction (2018).

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Bernard R Chaitman; Jeroen J Bax; David A Morrow; Harvey D White
Journal:  Glob Heart       Date:  2018-08-25

2.  Incidence and mortality of acute myocardial infarction. A population-based study including patients with out-of-hospital cardiac arrest.

Authors:  Shin-ichi Aso; Hiroshi Imamura; Yukio Sekiguchi; Tomomi Iwashita; Ryosuke Hirano; Uichi Ikeda; Kazufumi Okamoto
Journal:  Int Heart J       Date:  2011       Impact factor: 1.862

3.  Trends in Characteristics and Outcomes of Patients Undergoing Coronary Revascularization in the United States, 2003-2016.

Authors:  Mohamad Alkhouli; Fahad Alqahtani; Ankur Kalra; Sameer Gafoor; Mohamed Alhajji; Mohammed Alreshidan; David R Holmes; Amir Lerman
Journal:  JAMA Netw Open       Date:  2020-02-05

4.  A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis.

Authors:  Ravi Suppiah; Andrew Judge; Rajbir Batra; Oliver Flossmann; Lorraine Harper; Peter Höglund; M Kassim Javaid; David Jayne; Chetan Mukhtyar; Kerstin Westman; John C Davis; Gary S Hoffman; W Joseph McCune; Peter A Merkel; E William St Clair; Philip Seo; Robert Spiera; John H Stone; Raashid Luqmani
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

5.  Trends in the Prevalence of Cardiometabolic Multimorbidity in the United States, 1999-2018.

Authors:  Xunjie Cheng; Tianqi Ma; Feiyun Ouyang; Guogang Zhang; Yongping Bai
Journal:  Int J Environ Res Public Health       Date:  2022-04-14       Impact factor: 4.614

6.  Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis.

Authors:  Eswar Krishnan; Vijaya Bharathi Lingala; Gurkirpal Singh
Journal:  Circulation       Date:  2004-09-20       Impact factor: 29.690

Review 7.  The heart in vasculitis.

Authors:  Eli Miloslavsky; Sebastian Unizony
Journal:  Rheum Dis Clin North Am       Date:  2014-02       Impact factor: 2.670

Review 8.  Coronary artery vasculitis: a review of current literature.

Authors:  Shaun Khanna; Kartheek Garikapati; Daniel S L Goh; Kenneth Cho; Phillip Lo; Mohan V Bhojaraja; Surjit Tarafdar
Journal:  BMC Cardiovasc Disord       Date:  2021-01-06       Impact factor: 2.298

9.  Sudden death complicating a coronary arteritis: polyarteritis nodosa (case report).

Authors:  Mayssem Gabsi; Sarra Chenik; Houaida Mahfoudhi; Karima Taamallah; Nadhem Hajlaoui; Wafa Fehri
Journal:  Pan Afr Med J       Date:  2021-02-03

Review 10.  Global epidemiology of vasculitis.

Authors:  Richard A Watts; Gulen Hatemi; Jane C Burns; Aladdin J Mohammad
Journal:  Nat Rev Rheumatol       Date:  2021-12-01       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.